SIGA Technologies, Inc.
NASDAQ•SIGA
CEO: Dr. Dennis E. Hruby Ph.D.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Listing Date: 1997-09-10
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Contact Information
Market Cap
$309.85M
P/E (TTM)
15.3
11.2
Dividend Yield
13.9%
52W High
$9.62
52W Low
$4.10
52W Range
Rank30Top 19.5%
5.1
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.1 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Deep Research
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data